Apexigen Inc (APGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,802 | 23,443 | 1 | N/A | N/A |
| Marketable Securities | 1,997 | 12,917 | N/A | N/A | N/A |
| Other current assets | 1,776 | 0 | 0 | 0 | 0 |
| TOTAL | $21,193 | $38,041 | $1 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 150 | 245 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,512 | 810 | 96 | 0 | 0 |
| TOTAL | $1,662 | $1,055 | $96 | $N/A | $N/A |
| Total Assets | $22,855 | $39,096 | $97 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,343 | 4,487 | 0 | 0 | 0 |
| Accrued Expenses | 5,359 | 8,488 | N/A | N/A | N/A |
| TOTAL | $16,467 | $16,954 | $73 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,659 | 3,610 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 11 | 141 | 0 | 0 | 0 |
| TOTAL | $11 | $141 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,478 | $17,095 | $73 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,642 | 7,435 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 0 | N/A | N/A |
| Retained earnings | -176,793 | -144,724 | -2 | N/A | N/A |
| Other shareholders' equity | 0 | -4 | 0 | 0 | 0 |
| TOTAL | $6,377 | $22,001 | $24 | $N/A | $N/A |
| Total Liabilities And Equity | $22,855 | $39,096 | $97 | $0 | $0 |